Nanosized non-invasive probe to see blood vessel growth in tumours
July 24th, 2010 - 4:48 pm ICT by ANIWashington, July 23 (ANI): Using nanotechnology, material science, and the clinical imaging modality MRI, researchers have created a nanosized probe capable of noninvasively visualizing and quantifying the blood vessel growth in tumours in a preclinical model.
Led by Chase Kessinger, working together with Jinming Gao and colleagues at the University of Texas Southwestern Medical Center at Dallas.
“Imaging tumor angiogenesis is important in early detection, tumor stratification and post-therapy assessment of antiangiogenic drugs. Current clinical modality for angiogenesis imaging utilizes dynamic contrast enhancement MRI by small molecular contrast agents. The method is based on the measurement of permeability of the contrast probes in well-established solid tumors and is not very specific to detect the early on-set of vessel formation. The dual functional nanoprobes aim to image angiogenesis-specific tumor markers that are overly expressed in the tumor vasculature during the early phase of angiogenesis,” said Gao.
Together, the research team relied on nanotechnology and established super paramagnetic micellar nanoprobes (50-70 nm in diameter) with greatly improved MRI sensitivity over conventional small molecular agents.
The nanoprobe surface was functionalized with integrins that are a cyclic peptide that can specifically bind to overexpressed on the tumor endothelial cells.
The nanoprobes also had a fluorescent moiety used for the validation of targeted delivery to the tumor endothelial cells.
Studies in cancer cells validated the increased uptake of nanoprobes compared to non-targeted-nanoparticles.
The researchers employed a 3D high resolution acquisition method to visualize the accumulation of the micelle nanoprobes in tumors.
“Conventional image analysis of angiogenesis relies on the evaluation of ‘hot spot’ densities in 2D images. The 3D high resolution method allowed for the connection of the isolated ‘hot spots’ in 2D slices into 3D network structures, which greatly improves the accuracy of vessel identification and quantification,” said Gao.
The study has been published in the latest issue of Experimental Biology and Medicine. (ANI)
- Nanotechnology may lead to new liver cancer treatment - Feb 23, 2011
- Herbal remedy beats brain cancer - Jul 13, 2011
- Novel method might help block for tumour growth - Mar 15, 2011
- Newly-created bioactive peptides found to promote wound healing - Dec 08, 2010
- Key protein controlling blood vessel growth in mice's brain identified - Nov 12, 2010
- How breast cancer cells dodge immune system and survive - Feb 02, 2011
- Possible biomarker and therapeutic target for melanoma identified - Mar 18, 2011
- Imaging breakthrough to help docs see microscopic details inside our bodies - Nov 23, 2010
- Root cause of blood vessel damage in people with diabetes discovered - Jan 29, 2011
- Nanoprobes effective in delivering cancer drugs - Dec 15, 2009
- Morphine may block tumour growth - Jul 29, 2010
- Boffins identify 'gas pedal', 'brake' for uncontrolled cell growth - Aug 02, 2010
- Targeting protein helps keep melanoma tumour growth in check - Dec 10, 2010
- Boffins use nanoparticles as destructive beacons to destroy tumours - Jul 22, 2010
- Soon, a 'nano drug' jab that hits brain tumour's bullseye - Nov 06, 2010
Tags: acquisition method, antiangiogenic drugs, blood vessel growth, cancer cells, clinical imaging, contrast enhancement, conventional image, cyclic peptide, endothelial cells, nanoprobe, preclinical model, resolution method, southwestern medical center, texas southwestern medical, texas southwestern medical center, therapy assessment, tumor angiogenesis, tumor markers, university of texas southwestern medical center, university of texas southwestern medical center at dall